Scientific Sessions 2025  /  Diabetes, CKD and CVD Risk: From Mechanisms to Management  /  The Optimal Clinical Approach to Reducing Cardiovascular Risk from Diabetic Kidney Disease
Logo

American Heart Association

  31
  0

Final ID:

The Optimal Clinical Approach to Reducing Cardiovascular Risk from Diabetic Kidney Disease

  • Michos, Erin  ( John Hopkins , Baltimore , Maryland , United States )
    • Author Disclosures:
    Erin Michos: DO have relevant financial relationships ; Consultant:Arrowhead:Active (exists now) ; Consultant:Zoll:Past (completed) ; Consultant:Pfizer:Past (completed) ; Consultant:Novartis:Past (completed) ; Consultant:Esperion:Past (completed) ; Consultant:Amgen:Past (completed) ; Consultant:Novartis:Past (completed) ; Consultant:Edwards Lifescience:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:New Amsterdam:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Ionis:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Diabetes, CKD and CVD Risk: From Mechanisms to Management

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
The Expanding Therapeutic Options for Diabetic Kidney Disease: A Clinical Trial Overview

Neuen Brendon, Agarwal Rajiv, Rangaswami Janani

The synergistic impact of Diabetes and CKD on Cardiovascular Risk and Mortality

Pandey Ambarish, Deboer Ian

More abstracts from these authors:
Opportunities to Implement Cardiometabolic Health Promotion in the Cardiac Cath Lab

Michos Erin, Shapiro Michael

Panelist: Impact on Women

Michos Erin, Wenger Nanette

You have to be authorized to contact abstract author. Please, Login
Not Available